sulmazole has been researched along with Liver Cirrhosis in 1 studies
sulmazole: structure given in first source
sulmazole : An imidazopyridine that is 1H-imidazo[4,5-b]pyridine which is substituted at position 2 by a 2-methoxy-4-(methylsulfinyl)phenyl group. An A1 adenosine receptor antagonist, it was formerly used as a cardiotonic agent.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vicent, JL | 1 |
| van Reeth, O | 1 |
| Van Bogaert, E | 1 |
| Berre, J | 1 |
| Kahn, RJ | 1 |
1 other study available for sulmazole and Liver Cirrhosis
| Article | Year |
|---|---|
Use of the new inotropic agent ARL-115 BS to treat severe myocardial depression in septic shock.
Topics: Bronchopneumonia; Cardiotonic Agents; Hemodynamics; Humans; Imidazoles; Liver Cirrhosis; Male; Middl | 1986 |